A single-center 14-year follow-up study of the BalMedic^® bovine pericardial bioprosthetic valve.

ABSTRACT:

Background

The causes of valvular disease in China are complex, with a broad age distribution. For patients with early mechanical valve replacement, the quality of life is affected by postoperative anticoagulation-related complications. Since 2005, we have used bioprosthetic valves to provide more options for patients. In this study, we retrospectively analyzed the 14-year follow-up data of patients undergoing BalMedic bovine pericardial bioprosthetic valve replacement (manufacturer: Beijing Balance Medical Tech Co., Ltd.) to evaluate its intermediate- to long-term clinical effectiveness.

Methods

From 2005 to 2014, 336 BalMedic pericardial bioprosthesis valves were implanted in 299 patients (mean age 53.5 years, 59.86% female) at The First People's Hospital of Yulin. Among f

SUBMITTER: Lin M 

PROVIDER: S-EPMC7327367 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature